Measles IgM ELISA Kit

Full Name: Measles IgM ELISA Kit
Reactivity: Human
Sample Type: Plasma, Serum
Sensitivity: 1.07 U/ml


Measles which are sometimes referred to as rubeola, are an enveloped RNA virus, negative sense and single stranded that belong to the Paramyxoviridae family. An extremely contagious viral infection which is usually transmitted via respiratory secretions, it can infect the back of the throat and cells in the lungs.

Measles virus is known to show more severe expression among undernourished or younger children, displaying a higher incidence of hemorrhage (5-10% leading to lethal cases). Two of the most common methods which are used for detecting these infection are: antibody testing (IgG and IgM) and viral islation detection (RT-PCR).


Human measles IgM ELISA kit can be used for measuring in-vitro amounts of human IgM antibodies to measles virus (measles-IgM) present in serum and plasma samples. This assay has a minimum analytical sensitivity limit of 1.07 U/ml.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Measles antigen coated microtiter strips.
  • Negative Control (Calibrator A).
  • Cut-Off Standard (Calibrator B).
  • Weak Positive Control (Calibrator C).
  • Positive Control (Calibrator D).
  • Enzyme Conjugate.
  • Sample Diluent.
  • TMB Substrate.
  • Washing Buffer (10x).
  • Stop Solution.


The minimum detection sensitivity level of human IgM antibodies against measles (measles-IgM) using current measles virus IgM ELISA kit was 1.07 U/ml. The dynamic range for this assay is 1.0 – 150.0 U/ml.


– Intra-Assay-Precision: 7.0 %
– Inter-Assay-Precision: 2.8 – 8.7 %
– Inter-Lot-Precision: 5.5 – 13.4 %
– Analytical Sensitivity: 1.07 U/mL
– Recovery: 117 – 135 %
– Linearity: 95 – 136 %
– Cross-Reactivity: No cross-reactivity to Varicella and Mumps.
– Interferences: No interferences to triglycerides up to 5.0 mg/mL, bilirubin up to 0.3 mg/mL and hemoglobin up to 8.0 mg/mL.
– Clinical Specificity: 100 %
– Clinical Sensitivity: 67 %


  1. Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles. J Clin Lab Anal. (2013) 27 (6): 477-80. Sampedro A., et al.
  2. Comparison of two chemiluminescent immunoassays in the detection of measles IgM antibodies. J Virol Methods. (2016) 237: 38-39. Gómez-Camarasa C., et al.
  3. Measles investigation: a moving target. Am J Infect Control. (2014) 42 (8): 911-5. Helmecke M.R., et al.
  4. A point-of-care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid. Bull World Health Organ. (2011) 89 (9): 675-82. Warrener L., et al.


Online Enquiry Form

"*" indicates required fields

Please check mark information required:


Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford